Article
Inhibition of apoptosis and clonogenic survival of cells expressing crmA variants: optimal caspase substrates are not necessarily optimal inhibitors.
The EMBO journal - 15 Jan 1999
Ekert P G, Silke J, Vaux D L
Abstract excerpt
To study the role of various caspases during apoptosis, we have designed a series of caspase inhibitors based on the cowpox virus cytokine response modifier A (crmA) protein. Wild-type crmA inhibits caspases 1 and 8 and thereby protects cells from apoptosis triggered by ligation of CD95 or tumour necrosis factor (TNF) receptors, but it does not protect against death mediated by other caspases. By replacing the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
